You are about to leave jnjmedicaldevices.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
DERMABOND® PRINEO® Skin Closure System
Optimized healing and high patient satisfaction delivered through a powerful combination of 2-octyl cyanoacrylate (2-OCA) and self-adhering mesh.2,3
Features & Benefits
-
Improved Outcomes
DERMABOND PRINEO System is associated with significantly reduced readmission rates.1 In a retrospective study comparing DERMABOND PRINEO System and skin staples in TKA, DERMABOND PRINEO System is associated with significantly reduced readmission rates within 30, 60, and 90 days.*
-
Patient Comfort, Confidence, Satisfaction
Leads to higher overall patient satisfaction when compared to staples.† Leads to better cosmesis when compared to staples.†§ No postsurgical dressings may mean easier self-care and greater self-confidence for patients. If directed by the health care professional, patient may be able to shower immediately after procedure.
-
Strength and Protection
Microbial barrier protection proven 99% effective through 72 hours in vitro.4 Incisions closed with DERMABOND PRINEO System were ~33% stronger when compared with the average strength of staples‡ and were ~40% stronger when compared with the average strength of 4-0 suture.‡
Videos
DERMABOND® PRINEO® Skin Closure System
Spine Deformity Surgery with Dr. Suken Shah
0:02:46
Total Knee Arthroplasty with Dr. Ryan Nunley
0:01:17
Anterior Spine Surgery with Dr. Christopher Cain
0:04:33
DERMABOND PRINEO System 22 Application Video
0:02:34
DERMABOND PRINEO System 42 Application Video
0:02:59
DERMABOND PRINEO System Patient Journey
0:03:32
Total Abdominal Hysterectomy with Dr. Thad Denehy
0:02:52
Supporting Documentation
Product Support
DERMABOND PRINEO System 22 Information Sheet
DERMABOND PRINEO System 42 Information Sheet
DERMABOND PRINEO System 42 Application Guide
DERMABOND PRINEO System Patient Care Pad
DERMABOND® Portfolio Value Proposition
PRINEO Post-Op Care Sheet
References
* Premier Inpatient Database in Total Knee Arthroplasty (p<0.05). N=1,942; 2010-2015.
† Double-blinded quantitative research study comparing surgeon experience with DERMABOND PRINEO System and skin staples in total knee arthroplasty. N=83 orthopaedic surgeons. 90% c.I. Fielded June/July 2017.
§ in a TKA.
‡ Study performed ex vivo.
1. Stratafix and Prineo Premier Database Study RWE16-ETH-012. January 18, 2017. Ethicon, Inc.
2. Directions Research. PRINEO Claims Exploration US Patient & Surgeon Reference Data. 2017.
3. DERMABOND™ PRINEO™ Skin Closure System Instructions for Use. Ethicon, Inc.
4. Study Report for in vitro evaluation of microbial barrier properties of DERMABOND ProTape.
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
© Ethicon US, LLC. 2019. 085133-171129
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
This site is published by Ethicon US, LLC, which is solely responsible for its contents, and is intended for U.S. audiences only.
This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
Last updated February 20, 2019. The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.